Lisata Therapeutics Inc. (NASDAQ: LSTA)
$3.72
+0.0200 ( +0.54% ) 13.3K
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
Market Data
Open
$3.72
Previous close
$3.70
Volume
13.3K
Market cap
$30.78M
Day range
$3.63 - $3.80
52 week range
$1.95 - $3.87
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jan 11, 2024 |
4 | Insider transactions | 1 | Jan 11, 2024 |
4 | Insider transactions | 1 | Jan 11, 2024 |
4 | Insider transactions | 1 | Jan 11, 2024 |
4 | Insider transactions | 1 | Jan 11, 2024 |
4 | Insider transactions | 1 | Jan 11, 2024 |
4 | Insider transactions | 1 | Jan 11, 2024 |
10-q | Quarterly Reports | 79 | Nov 02, 2023 |
8-k | 8K-related | 65 | Nov 02, 2023 |
4 | Insider transactions | 1 | Sep 05, 2023 |